Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Intervention1: Sevoflurane: After laryngeal mask airway removal, the respiratory adverse events (cough, bronchospasm, laryngospasm, desaturation, stridor) between Tiva with propofol and sevoflurane wi
Sponsors
Armed Forces Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children undergoing minor surgeries of duration less than 2 hours. 2. Patient should be eligible for LMA insertion. 3. Children with American Society of Anesthesiologist (ASA) status 1 - 2.
Exclusion criteria
Exclusion criteria: 1. Pediatric patients with acute exacerbation of asthma. 2. Pediatric patients with congenital heart disease. 3. Pediatric patients with neurologic disorders. 4. Pediatric patients with full stomach. 5. Pediatric patients with hiatal heria. 6. Pediatric patients with known of predicted difficult airway. 7. Pediatric patients with facial or airway anomalies. 8. Pediatric patients with major abdominal or thoracic surgery. 9. Pediatric patients who had more than 3 attempts at LMA mask insertion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare occurance of atleast one perioperative respiratory adverse event between TIVA with propofol & sevoflurane.Timepoint: Immediately till Half an hour post laryngeal mask airway removal | — |
Secondary
| Measure | Time frame |
|---|---|
| The individual adverse event following removal of LMA mask.Timepoint: Immediately till Half an hour post laryngeal mask airway removal;The severity of airway hyper reactivity using the airway hyper reactivity score of Pappas et al. Timepoint: Immediately post laryngeal mask airway removal | — |
Countries
India
Contacts
Public ContactDr Gunjan Singh
Armed Forces Medical College
Outcome results
None listed